Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.87 USD 0.34% Market Closed
Market Cap: 337.5m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Other Current Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Other Current Assets
$241k
CAGR 3-Years
189%
CAGR 5-Years
10%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Other Current Assets
$1.3m
CAGR 3-Years
6%
CAGR 5-Years
17%
CAGR 10-Years
17%
Urogen Pharma Ltd
NASDAQ:URGN
Other Current Assets
$15.1m
CAGR 3-Years
27%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Other Current Assets
$314k
CAGR 3-Years
-12%
CAGR 5-Years
1%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Other Current Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kamada Ltd
Glance View

Market Cap
337.4m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.35 USD
Overvaluation 9%
Intrinsic Value
Price

See Also

Back to Top